General & Plastic Surgery Devices - Fiji

The General & Plastic Surgery Devices market market in Fiji is anticipated to achieve a revenue of US$1.44m in 2024.
It is predicted that the revenue will experience a compound annual growth rate (CAGR 2024-2029) of 6.36%, leading to a market volume of US$1.96m by 2029.
In comparison to other countries worldwide, the United States is expected to generate the highest revenue of US$9.84bn in 2024.
Despite being a small island nation, Fiji has seen a growing demand for General & Plastic Surgery Devices, with an increasing number of clinics offering these services.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in Fiji is experiencing steady growth and development due to various factors.

Customer preferences: Customers in Fiji are increasingly seeking cosmetic surgery procedures to enhance their appearance and boost their self-confidence. The demand for plastic surgery devices such as breast implants, facial implants, and liposuction devices is on the rise as people in Fiji aspire to achieve beauty standards influenced by global trends. Additionally, there is a growing awareness about the benefits of reconstructive surgery, leading to an increased demand for devices used in reconstructive procedures.

Trends in the market: One of the key trends in the General & Plastic Surgery Devices market in Fiji is the adoption of minimally invasive procedures. Patients are increasingly opting for less invasive surgeries that offer shorter recovery times and fewer complications. This trend is driving the demand for devices such as laser systems, dermal fillers, and non-surgical fat reduction devices. The market is also witnessing a shift towards personalized and customized solutions, with surgeons and patients looking for devices that can be tailored to individual needs and preferences.

Local special circumstances: Fiji's tourism industry plays a significant role in the growth of the General & Plastic Surgery Devices market. The country attracts a large number of medical tourists who come to Fiji specifically for cosmetic and reconstructive surgeries. This influx of medical tourists contributes to the overall demand for plastic surgery devices in the country. Additionally, Fiji's proximity to Australia and New Zealand makes it a convenient destination for patients from these countries who are seeking affordable plastic surgery options.

Underlying macroeconomic factors: Fiji's growing economy and rising disposable income levels have a positive impact on the General & Plastic Surgery Devices market. As people have more disposable income, they are more willing to spend on cosmetic and reconstructive surgeries. The government's efforts to promote medical tourism and attract foreign investment in the healthcare sector are also contributing to the growth of the market. Furthermore, advancements in technology and the availability of innovative plastic surgery devices are driving the market forward. In conclusion, the General & Plastic Surgery Devices market in Fiji is witnessing growth and development due to increasing customer preferences for cosmetic and reconstructive surgeries, the adoption of minimally invasive procedures, the influence of medical tourism, and the country's growing economy. These factors, coupled with advancements in technology, are expected to continue driving the market in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.